MedPage Today on MSN
FDA opens early access to novel pancreatic cancer drug generating buzz
Requests for treatment with daraxonrasib must come from licensed U.S. physicians ...
Q1 2026 earnings call: commercialization timeline, EAP traction, service lab progress, cash runway through 2027 & risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results